Chan Gao

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma

Ting Chen, Jia Liu, Bo Li, 2022, Frontiers in Oncology.

Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape.

M. Kortylewski, J. Rossi, Jiehua Zhou, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.

M. Kortylewski, Cedric E. Dos Santos, P. Swiderski, 2014, Blood.

systemic antitumor immunity Leukemia cell-targeted STAT3 silencing and TLR9-triggering generate

P. Swiderski, S. Forman, R. Bhatia, 2013 .

systemic antitumor immunity targeted STAT 3 silencing and TLR 9 triggering generate − Leukemia cell

M. Kortylewski, P. Swiderski, S. Forman, 2013 .

TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs

Yate-Ching Yuan, M. Kortylewski, S. Pal, 2017, Journal of leukocyte biology.

TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.

P. Chu, M. Kortylewski, S. Pal, 2013, Cancer research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.

M. Kortylewski, Cedric E. Dos Santos, P. Swiderski, 2014, Blood.